The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Site-Specific PEGylation of Therapeutic Proteins
Open accessAbstract
The use of proteins as therapeutics has a long history and is becoming ever more common in modern medicine. While the number of protein-based drugs is growing every year, significant problems still remain with their use. Among these problems are rapid degradation and excretion from patients, thus requiring frequent dosing, which in turn increases the chances for an immunological response as well as increasing the cost of therapy. One of the main strategies to alleviate these problems is to link a polyethylene glycol (PEG) group to the protein of interest. This process, called PEGylation, has grown dramatically in recent years resulting in several approved drugs. Installing a single PEG chain at a defined site in a protein is challenging. Recently, there is has been considerable research into various methods for the site-specific PEGylation of proteins. This review seeks to summarize that work and provide background and context for how site-specific PEGylation is performed. After introducing the topic of site-specific PEGylation, recent developments using chemical methods are described. That is followed by a more extensive discussion of bioorthogonal reactions and enzymatic labeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
Sletten, E. M., & Bertozzi, C. R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900942 · Cited by 3,165
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161 · cited 5×
“While histidine tagged proteins are not yet FDA approved from human therapeutics, demonstrating the utility and versatility of this tag for PEGylating therapeutics could lead to swifter approval and/or the development of other similar, yet regulatory acceptable, tags.”
InfluentialChemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00022-4 · Cited by 1,604
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
Lau, G. K. K., Piratvisuth, T., Luo, K. X., Marcellin, P., Thongsawat, S., Cooksley, G., Gane, E., Fried, M. W., Chow, W. C., Paik, S. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043470 · Cited by 1,519
Abuchowski, A., van Es, T., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems
Terpe, K. (2003) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-002-1158-6 · Cited by 1,342
Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,274
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
McHutchison, J. G., Lawitz, E. J., Shiffman, M. L., Muir, A. J., Galler, G. W., McCone, J., Nyberg, L. M., Lee, W. M., Ghalib, R. H., Schiff, E. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808010 · Cited by 1,190
The Impact of PEGylation on Biological Therapies
Veronese, F. M., & Mero, A. (2008) · BioDrugs · doi:10.2165/00063030-200822050-00004 · Cited by 1,034
Addition of p-Azido-l-phenylalanine to the Genetic Code of Escherichia coli
Chin, J. W., Santoro, S. W., Martin, A. B., King, D. S., Wang, L., & Schultz, P. G. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027007w · Cited by 721
State of the art in PEGylation: The great versatility achieved after forty years of research
Pasut, G., & Veronese, F. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.037 · Cited by 720
PEGylation of therapeutic proteins
Jevševar, S., Kunstelj, M., & Porekar, V. G. (2010) · Biotechnology Journal · doi:10.1002/biot.200900218 · Cited by 681
FDA-approved poly(ethylene glycol)–protein conjugate drugs
Alconcel, S. N. S., Baas, A. S., & Maynard, H. D. (2011) · Polymer Chemistry · doi:10.1039/c1py00034a · Cited by 643
Green, M. D., Koelbl, H., Baselga, J., Galid, A., Guillem, V., Gascon, P., Siena, S., Lalisang, R. I., Samonigg, H., Clemens, M. R., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg019 · Cited by 586
Wang, L., Xie, J., & Schultz, P. G. (2006) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.35.101105.121507 · Cited by 582
Strategies for extended serum half-life of protein therapeutics
Kontermann, R. E. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.06.012 · Cited by 573
Immunogenicity of protein therapeutics
De Groot, A. S., & Scott, D. W. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.07.011 · Cited by 545
Sortagging: a versatile method for protein labeling
Popp, M. W., Antos, J. M., Grotenbreg, G. M., Spooner, E., & Ploegh, H. L. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.31 · Cited by 541
Holmes, F. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.727 · Cited by 537
Ordás, I., Mould, D. R., Feagan, B. G., & Sandborn, W. J. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.328 · Cited by 498
The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
Fishburn, C. S. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21278 · Cited by 474
Introduction to current and future protein therapeutics: A protein engineering perspective
Carter, P. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.013 · Cited by 467
Treatment of Adenosine Deaminase Deficiency with Polyethylene Glycol–Modified Adenosine Deaminase
Hershfield, M. S., Buckley, R. H., Greenberg, M. L., Melton, A. L., Schiff, R., Hatem, C., Kurtzberg, J., Markert, M. L., Kobayashi, R. H., Kobayashi, A. L., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703053161005 · Cited by 443
Introducing genetically encoded aldehydes into proteins
Carrico, I. S., Carlson, B. L., & Bertozzi, C. R. (2007) · Nature Chemical Biology · doi:10.1038/nchembio878 · Cited by 438
Wursthorn, K., Lutgehetmann, M., Dandri, M., Volz, T., Buggisch, P., Zollner, B., Longerich, T., Schirmacher, P., Metzler, F., Zankel, M., et al. (2006) · Hepatology · doi:10.1002/hep.21282 · Cited by 438
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
Dierks, T., Schmidt, B., Borissenko, L. V., Peng, J., Preusser, A., Mariappan, M., & von Figura, K. (2003) · Cell · doi:10.1016/s0092-8674(03)00347-7 · Cited by 386
Tyrosine Bioconjugation through Aqueous Ene-Type Reactions: A Click-Like Reaction for Tyrosine
Ban, H., Gavrilyuk, J., & Barbas, C. F. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909062q · Cited by 343
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.025 · Cited by 334
Pegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Mono-N-terminal poly(ethylene glycol)–protein conjugates
Kinstler, O., Molineux, G., Treuheit, M., Ladd, D., & Gegg, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00023-6 · Cited by 306
PEG-uricase in the management of treatment-resistant gout and hyperuricemia
Sherman, M. R., Saifer, M. G. P., & Perez-Ruiz, F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.011 · Cited by 291
Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
Badescu, G., Bryant, P., Bird, M., Henseleit, K., Swierkosz, J., Parekh, V., Tommasi, R., Pawlisz, E., Jurlewicz, K., Farys, M., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500148x · Cited by 290
Protein conjugation with genetically encoded unnatural amino acids
Kim, C. H., Axup, J. Y., & Schultz, P. G. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.04.017 · Cited by 269
Site-specific PEGylation of proteins containing unnatural amino acids
Deiters, A., Cropp, T. A., Summerer, D., Mukherji, M., & Schultz, P. G. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.059 · Cited by 262
Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase
Fontana, A., Spolaore, B., Mero, A., & Veronese, F. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.015 · Cited by 249
Enzymatic Labeling of Proteins: Techniques and Approaches
Rashidian, M., Dozier, J. K., & Distefano, M. D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400102w · Cited by 244
Self-citationCharacterization and Stability of N-terminally PEGylated rhG-CSF
Kinstler, O. B., Brems, D. N., Lauren, S. L., Paige, A. G., Hamburger, J. B., & Treuheit, M. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016042220817 · Cited by 239
Sortase A as a Novel Molecular “Stapler” for Sequence-Specific Protein Conjugation
Parthasarathy, R., Subramanian, S., & Boder, E. T. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060339w · Cited by 218
Levy, Y., Hershfield, M. S., Fernandez-Mejia, C., Polmar, S. H., Scudiery, D., Berger, M., & Sorensen, R. U. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80271-3 · Cited by 215
Nonnatural Amino Acids for Site-Specific Protein Conjugation
de Graaf, A. J., Kooijman, M., Hennink, W. E., & Mastrobattista, E. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800294a · Cited by 205
Sortase‐Mediated Ligation: A Gift from Gram‐Positive Bacteria to Protein Engineering
Tsukiji, S., & Nagamune, T. (2009) · ChemBioChem · doi:10.1002/cbic.200800724 · Cited by 200
Ban, H., Nagano, M., Gavrilyuk, J., Hakamata, W., Inokuma, T., & Barbas, C. F. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300665t · Cited by 200
Optimized clinical performance of growth hormone with an expanded genetic code
Cho, H., Daniel, T., Buechler, Y. J., Litzinger, D. C., Maio, Z., Putnam, A.-M. H., Kraynov, V. S., Sim, B.-C., Bussell, S., Javahishvili, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100387108 · Cited by 199
Obstacles and pitfalls in the PEGylation of therapeutic proteins.
Gaberc‐Porekar, V., Zore, I., Podobnik, B., & Menart, V. (2008) · PubMed · Cited by 197
Goel, N., & Stephens, S. (2010) · mAbs · doi:10.4161/mabs.2.2.11271 · Cited by 188
Sortase-catalyzed transformations that improve the properties of cytokines
Popp, M. W., Dougan, S. K., Chuang, T.-Y., Spooner, E., & Ploegh, H. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016863108 · Cited by 183
Site-Specific Attachment of Functionalized Poly(ethylene glycol) to the Amino Terminus of Proteins
Gaertner, H. F., & Offord, R. E. (1996) · Bioconjugate Chemistry · doi:10.1021/bc950074d · Cited by 174
GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli
DeFrees, S., Wang, Z.-G., Xing, R., Scott, A. E., Wang, J., Zopf, D., Gouty, D. L., Sjoberg, E. R., Panneerselvam, K., Brinkman-Van der Linden, E. C. M., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwl004 · Cited by 174
Site-Specific PEGylation of Protein Disulfide Bonds Using a Three-Carbon Bridge
Balan, S., Choi, J.-W., Godwin, A., Teo, I., Laborde, C. M., Heidelberger, S., Zloh, M., Shaunak, S., & Brocchini, S. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0601471 · Cited by 172
Foser, S., Schacher, A., Weyer, K. A., Brugger, D., Dietel, E., Marti, S., & Schreitmüller, T. (2003) · Protein Expression and Purification · doi:10.1016/s1046-5928(03)00055-x · Cited by 165
Irreversible Site‐Specific Hydrazinolysis of Proteins by Use of Sortase
Li, Y., Li, Y., Pan, M., Kong, X., Huang, Y., Hong, Z., & Liu, L. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310010 · Cited by 164
Mu, J., Pinkstaff, J., Li, Z., Skidmore, L., Li, N., Myler, H., Dallas-Yang, Q., Putnam, A.-M., Yao, J., Bussell, S., et al. (2012) · Diabetes · doi:10.2337/db11-0838 · Cited by 162
Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia
Macdougall, I. C., & Eckardt, K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69120-4 · Cited by 146
Østergaard, H., Bjelke, J. R., Hansen, L., Petersen, L. C., Pedersen, A. A., Elm, T., Møller, F., Hermit, M. B., Holm, P. K., Krogh, T. N., et al. (2011) · Blood · doi:10.1182/blood-2011-02-336172 · Cited by 145
Conjugation-Induced Fluorescent Labeling of Proteins and Polymers Using Dithiomaleimides
Robin, M. P., Wilson, P., Mabire, A. B., Kiviaho, J. K., Raymond, J. E., Haddleton, D. M., & O’Reilly, R. K. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3105494 · Cited by 123
Stennicke, H. R., Kjalke, M., Karpf, D. M., Balling, K. W., Johansen, P. B., Elm, T., Øvlisen, K., Møller, F., Holmberg, H. L., Gudme, C. N., et al. (2013) · Blood · doi:10.1182/blood-2012-01-407494 · Cited by 119
Rashidian, M., Mahmoodi, M. M., Shah, R. M., Dozier, J. K., Wagner, C. R., & Distefano, M. D. (2013) · Bioconjugate Chemistry · doi:10.1021/bc3004167 · Cited by 118
Self-citationFormulation of Neulasta® (pegfilgrastim)
Piedmonte, D. M., & Treuheit, M. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.017 · Cited by 117
Chemoenzymatic Reversible Immobilization and Labeling of Proteins without Prior Purification
Rashidian, M., Song, J. M., Pricer, R. E., & Distefano, M. D. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211308s · Cited by 114
Self-citationSelective Labeling of Proteins by Using Protein Farnesyltransferase
Duckworth, B. P., Zhang, Z., Hosokawa, A., & Distefano, M. D. (2006) · ChemBioChem · doi:10.1002/cbic.200600340 · Cited by 114
Self-citationSelf‐Liganded Suzuki–Miyaura Coupling for Site‐Selective Protein PEGylation
Dumas, A., Spicer, C. D., Gao, Z., Takehana, T., Lin, Y. A., Yasukohchi, T., & Davis, B. G. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208626 · Cited by 108
Mero, A., Spolaore, B., Veronese, F. M., & Fontana, A. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800427n · Cited by 97
Further Studies on the Site-Specific Protein Modification by Microbial Transglutaminase
Sato, H., Hayashi, E., Yamada, N., Yatagai, M., & Takahara, Y. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000132h · Cited by 94
Schlesinger, N., Yasothan, U., & Kirkpatrick, P. N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3349 · Cited by 91
New Strategy for the Extension of the Serum Half-Life of Antibody Fragments
Trüssel, S., Dumelin, C. E., Frey, K., Villa, A., Buller, F., & Neri, D. (2009) · Bioconjugate Chemistry · doi:10.1021/bc9002772 · Cited by 89
Site-Specific PEGylation at Histidine Tags
Cong, Y., Pawlisz, E., Bryant, P., Balan, S., Laurine, E., Tommasi, R., Ruchi, S., Dubey, S., Peciak, K., Bird, M., et al. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200530x · Cited by 87
Nagata, S., & Pastan, I. H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.014 · Cited by 80
Bio‐Click Chemistry: Enzymatic Functionalization of PEGylated Capsules for Targeting Applications
Leung, M. K. M., Hagemeyer, C. E., Johnston, A. P. R., Gonzales, C., Kamphuis, M. M. J., Ardipradja, K., Such, G. K., Peter, K., & Caruso, F. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203612 · Cited by 74
Mero, A., Schiavon, M., Veronese, F. M., & Pasut, G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.024 · Cited by 73
Cazalis, C. S., Haller, C. A., Sease-Cargo, L., & Chaikof, E. L. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049903y · Cited by 72
Recombinant Protein Hydrazides: Application to Site-Specific Protein PEGylation
Thom, J., Anderson, D., McGregor, J., & Cotton, G. (2011) · Bioconjugate Chemistry · doi:10.1021/bc2001374 · Cited by 70
Collins, P. W., MØSS, J., Knobe, K. E., GROTH, A., Colberg, T., & WATSON, E. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12000 · Cited by 66
Antibodies against Erythropoietin and Other Protein‐Based Therapeutics: An Overview
Kromminga, A., & Schellekens, H. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1313.027 · Cited by 63
Melmed, G., Targan, S., Yasothan, U., Hanicq, D., & Kirkpatrick, P. J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2654 · Cited by 63
Polyethylene Glycol Modified FGF21 Engineered to Maximize Potency and Minimize Vacuole Formation
Xu, J., Bussiere, J. L., Yie, J., Sickmier, E. A., An, P., Belouski, E., Stanislaus, S., & Walker, K. W. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300603k · Cited by 62
Longer action means better drug: Tuning up protein therapeutics
Szlachcic, A., Zakrzewska, M., & Otlewski, J. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.03.005 · Cited by 62
Li, Y., Yang, M., Huang, Y., Song, X., Liu, L., & Chen, P. R. (2012) · Chemical Science · doi:10.1039/c2sc20433a · Cited by 61
Generation and biochemical characterization of glycoPEGylated factor VIIa derivatives
Østergaard, H., Bayer, R. J., Kalo, M. S., et al. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-04-0268 · Cited by 58
Certolizumab Pegol: In Crohn??s Disease
Blick, S. K. A., & Curran, M. P. (2007) · BioDrugs · doi:10.2165/00063030-200721030-00006 · Cited by 53
Kim, T. H., Jiang, H. H., Lim, S. M., Youn, Y. S., Choi, K. Y., Lee, S., Chen, X. S., Byun, Y., & Lee, K. C. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300265n · Cited by 51
Sato, H., Ikeda, M., Suzuki, K., & Hirayama, K. (1996) · Biochemistry · doi:10.1021/bi952616k · Cited by 44
Danial, M., van Dulmen, T. H. H., Aleksandrowicz, J., Pötgens, A. J. G., & Klok, H. (2012) · Bioconjugate Chemistry · doi:10.1021/bc3002248 · Cited by 44
Site‐directed enzymatic PEGylation of the human granulocyte colony‐stimulating factor
Maullu, C., Raimondo, D., Caboi, F., Giorgetti, A., Sergi, M., Valentini, M. C., Tonon, G., & Tramontano, A. L. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07387.x · Cited by 41
Creating the next generation of protein therapeutics through rational drug design.
Szymkowski, D. E. (2005) · PubMed · Cited by 40
Nairn, N. W., Shanebeck, K. D., Wang, A., Graddis, T. J., VanBrunt, M. P., Thornton, K. C., & Grabstein, K. H. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300295x · Cited by 40
Selective labeling of polypeptides using protein farnesyltransferase via rapid oxime ligation
Rashidian, M., Dozier, J. K., Lenevich, S., & Distefano, M. D. (2010) · Chemical Communications · doi:10.1039/c0cc03305g · Cited by 39
Self-citationEngineering Protein Farnesyltransferase for Enzymatic Protein Labeling Applications
Dozier, J. K., Khatwani, S. L., Wollack, J. W., Wang, Y.-C., Schmidt‐Dannert, C., & Distefano, M. D. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500240p · Cited by 38
Self-citationPandey, B. K., Smith, M. S., Torgerson, C. D., Lawrence, P. B., Matthews, S. S., Watkins, E. M., Groves, M. L., Prigozhin, M. B., & Price, J. L. (2013) · Bioconjugate Chemistry · doi:10.1021/bc3006122 · Cited by 38
Glycoengineering Approach to Half-Life Extension of Recombinant Biotherapeutics
Chen, C., Constantinou, A., Chester, K. A., Vyas, B., Canis, K., Haslam, S. M., Dell, A., Epenetos, A. A., & Deonarain, M. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200624a · Cited by 37
Lindsley, C. W. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400107y · Cited by 36
Irreversible Site‐Specific Hydrazinolysis of Proteins by Use of Sortase
Li, Y., Li, Y., Pan, M., Kong, X., Huang, Y., Hong, Z., & Liu, L. (2014) · Angewandte Chemie · doi:10.1002/ange.201310010 · Cited by 33
Self‐Assembly of Antibodies by Chemical Induction
Li, Q., Hapka, D., Chen, H., Vallera, D. A., & Wagner, C. R. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803507 · Cited by 28
Biophysical characterisation of GlycoPEGylated recombinant human factor VIIa
Plesner, B., Westh, P., & Nielsen, A. D. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.034 · Cited by 27
Unterweger, B., Stoisser, T., Leitgeb, S., Birner‐Gruenberger, R., & Nidetzky, B. (2012) · Bioconjugate Chemistry · doi:10.1021/bc2006847 · Cited by 25
Bio‐Click Chemistry: Enzymatic Functionalization of PEGylated Capsules for Targeting Applications
Leung, M. K. M., Hagemeyer, C. E., Johnston, A. P. R., Gonzales, C., Kamphuis, M. M. J., Ardipradja, K., Such, G. K., Peter, K., & Caruso, F. (2012) · Angewandte Chemie · doi:10.1002/ange.201203612 · Cited by 24
Carbohydrate-Mediated Polyethylene Glycol Conjugation of TSH Improves Its Pharmacological Properties
Park, A., Honey, D. M., Hou, L., Jaworski, J. A., Zarazinski, C., Searles, M., Braithwaite, C., Kingsbury, J. S., Kyazike, J., Culm-Merdek, K., et al. (2013) · Endocrinology · doi:10.1210/en.2012-2010 · Cited by 23
Intrinsic bioconjugation for site-specific protein PEGylation at N-terminal serine
Levine, P. M., Craven, T. W., Bonneau, R., et al. (2014) · Chemical Communications · doi:10.1039/c4cc01928h · Cited by 21
N-PEGylation of a Reverse Turn Is Stabilizing in Multiple Sequence Contexts, unlike N-GlcNAcylation
Price, J. L., Powers, E. T., & Kelly, J. W. (2011) · ACS Chemical Biology · doi:10.1021/cb200277u · Cited by 20
Site-Specific PEGylation of Human Thyroid Stimulating Hormone to Prolong Duration of Action
Qiu, H., Boudanova, E., Park, A., Jaworski, J. A., Honey, D. M., Zarazinski, C., Greene, B., Kingsbury, J. S., Boucher, S., Pollock, J., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300519h · Cited by 20
Wang, Y.-C., & Distefano, M. D. (2012) · Chemical Communications · doi:10.1039/c2cc31713c · Cited by 18
Self-citationPEGylation of human growth hormone: strategies and properties
Finn, R. F. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8679-5_11 · Cited by 12
Hovlid, M. L., Edelstein, R. L., Henry, O., et al. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00914.x · Cited by 9
Volpato, J. P., Mayotte, N., Fossati, E., Guerrero, V., Sauvageau, G., & Pelletier, J. N. (2010) · Journal of Molecular Recognition · doi:10.1002/jmr.1037 · Cited by 6
Gao, M., Tong, Y. A., Gao, X., & Yao, W. (2013) · Drug Development Research · doi:10.1002/ddr.21059 · Cited by 3
Cited by
Herzberger, J., Niederer, K., Pohlit, H., Seiwert, J., Worm, M., Wurm, F. R., & Frey, H. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00441 · Cited by 865
Shi, D., Beasock, D., Fessler, A., Szebeni, J., Ljubimova, J. Y., Afonin, K. A., & Dobrovolskaia, M. A. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114079 · Cited by 535
Targeting the N terminus for site-selective protein modification
Rosen, C. B., & Francis, M. B. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2416 · Cited by 389
Peptide-based drug discovery: Current status and recent advances
Sharma, K., Sharma, K. K., Sharma, A., & Jain, R. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103464 · Cited by 313
Considerations for the Design of Antibody-Based Therapeutics
Goulet, D. R., & Atkins, W. M. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.031 · Cited by 302
Metadata
- Authors
- Dozier, J., & Distefano, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-10-28
- Volume
- 16
- Issue
- 10
- Pages
- 25831-25864
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W1839516892
- Cited by
- 287
- References
- 105
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.